BAILEY BURGAN: Open Payments
NPI 1871244632 · BEREA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 31 payments from 7 companies in 2025. Trend: 2023 $302 · 2024 $584 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $196 |
| Regeneron Healthcare Solutions, Inc. | 8 | $193 |
| Amgen Inc. | 6 | $92 |
| Smith+Nephew, Inc. | 1 | $59 |
| ABBVIE INC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: DUPIXENT, TAVNEOS, TULA, UBRELVY, QULIPTA, FASENRA, LIBTAYO, TEZSPIRE.
Industry payments across OH — which companies pay providers there.
